Response to Comments: Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

This document (A59518) is a response-to-comments summary for Proposed LCD DL36377 on skin substitute grafts and cellular/tissue-based products for diabetic foot ulcers and venous leg ulcers; it reports that public comments were reviewed and incorporated into the final LCD as appropriate. The response document itself does not specify clinical coverage criteria, limitations, documentation requirements, or frequency limits — those are in the final LCD DL36377 and require manual extraction for policy application.

"This document is a summary of public comments and contractor responses to Proposed Local Coverage Determination (LCD) DL36377 regarding skin substitute grafts/cellular and tissue-based products for..."

Sign up to see full coverage criteria, indications, and limitations.